Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study
- PMID: 2169192
- PMCID: PMC1877533
Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study
Abstract
Antibodies directed against three regions of tau, ubiquitin, and B-amyloid were used in a histologic study of neurofibrillary degeneration in Alzheimer's disease to distinguish two populations of neurofibrillary tangles. Intracellular tangles were immunolabeled exclusively by two antibodies raised against antigens in the fuzzy coat of the paired helical filament (PHF). Extracellular tangles were distinguished by selective immunolabeling with a monoclonal antibody raised against antigens in the PHF core. This was associated with removal of the fuzzy coat and exposure of PHF-core epitopes. In the transition from intracellular to extracellular compartments in vivo, tangles appeared to undergo changes similar to protease digestion in vitro. The transition was associated with the appearance of amyloid immunoreactivity. These findings suggest that tangle degradation occurs in a series of distinct stages, including ubiquitination of some unknown molecule, a change in tau immunoreactivity, and partial proteolysis of tangle-bound tau in extracellular tangles.
Similar articles
-
Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.Lab Invest. 1989 Mar;60(3):375-89. Lab Invest. 1989. PMID: 2494388
-
Tau and ubiquitin immunoreactivity at different stages of formation of Alzheimer neurofibrillary tangles.Prog Clin Biol Res. 1989;317:837-48. Prog Clin Biol Res. 1989. PMID: 2557644
-
Neurofibrillary tangles and the neuronal cytoskeleton.J Neural Transm Suppl. 1987;24:191-6. J Neural Transm Suppl. 1987. PMID: 3119774 Review.
-
Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.Ann Neurol. 1987 Oct;22(4):514-20. doi: 10.1002/ana.410220411. Ann Neurol. 1987. PMID: 2963585
-
[Pathology of the cytoskeleton in Alzheimer's disease and disorders related to this disease].Gac Med Mex. 1990 Sep-Oct;126(5):367-73. Gac Med Mex. 1990. PMID: 1966495 Review. Spanish.
Cited by
-
Protein truncation as a common denominator of human neurodegenerative foldopathies.Mol Neurobiol. 2013 Dec;48(3):516-32. doi: 10.1007/s12035-013-8440-8. Epub 2013 Mar 21. Mol Neurobiol. 2013. PMID: 23516100 Review.
-
Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles.Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2098-102. doi: 10.1073/pnas.88.6.2098. Proc Natl Acad Sci U S A. 1991. PMID: 1706517 Free PMC article.
-
Lack of ubiquitin immunoreactivities at both ends of neuropil threads. Possible bidirectional growth of neuropil threads.Am J Pathol. 1992 Feb;140(2):277-82. Am J Pathol. 1992. PMID: 1310831 Free PMC article.
-
Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease.Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5842-6. doi: 10.1073/pnas.88.13.5842. Proc Natl Acad Sci U S A. 1991. PMID: 1905817 Free PMC article.
-
Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11213-8. doi: 10.1073/pnas.93.20.11213. Proc Natl Acad Sci U S A. 1996. PMID: 8855335 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical